4/A

PRIMARY DOCUMENT

Company: INTERPACE BIOSCIENCES, INC.
Filed: March 8, 2019
Period of Report: December 5, 2018
Accession Number: 0001192482-19-000124

View Document ↗ View on SEC.gov ↗